
Animal Derivatives Market Report 2026
Global Outlook – By Type (Immunoglobulin, Serum Albumin, Fibrinogen, Other Types), By Animal Type (Ovine, Bovine), By Application (Food And Beverages, Pharmaceutical Industry, Cosmetic Industry, Pet Food Industry, Other Applications) – Market Size, Trends, Strategies, and Forecast to 2035
Animal Derivatives Market Overview
• Animal Derivatives market size has reached to $13.27 billion in 2025 • Expected to grow to $18.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Rising Urbanization Spurs Growth In Animal Derivatives Market • Market Trend: Innovative Products Drive Momentum In Animal Derivatives Market • North America was the largest region in 2025.What Is Covered Under Animal Derivatives Market?
Animal derivatives refer to substances or products that are derived from animals. Animal derivatives are used in various industries and products as a source of nutrients. The main types of animal derivatives are immunoglobulin, serum albumin, fibrinogen, and others. Immunoglobulin refers to a class of proteins produced by the immune system in response to foreign substances called antigens. The animal types involved are ovine and bovine, which are used for food and beverages, pharmaceutical industry, cosmetic industry, pet food industry, and others.
What Is The Animal Derivatives Market Size and Share 2026?
The animal derivatives market size has grown strongly in recent years. It will grow from $13.27 billion in 2025 to $14.06 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to long-standing use of animal derivatives in pharmaceuticals, growth of livestock processing industries, increasing demand from food and beverage sector, expansion of pet food industry, established applications in diagnostics and research.What Is The Animal Derivatives Market Growth Forecast?
The animal derivatives market size is expected to see strong growth in the next few years. It will grow to $18.27 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for biologics and plasma-derived products, growth in cosmetic and personal care formulations, increasing focus on immune-based therapies, expansion of nutraceutical and functional food markets, advancements in purification and processing technologies. Major trends in the forecast period include growing demand for animal-derived proteins in healthcare, increasing utilization of immunoglobulins in therapeutics, rising use of animal derivatives in pet nutrition, expansion of applications in functional foods and beverages, increasing focus on quality and purity of animal-derived ingredients.Global Animal Derivatives Market Segmentation
1) By Type: Immunoglobulin, Serum Albumin, Fibrinogen, Other Types 2) By Animal Type: Ovine, Bovine 3) By Application: Food And Beverages, Pharmaceutical Industry, Cosmetic Industry, Pet Food Industry, Other Applications Subsegments: 1) By Immunoglobulin: IgG (Immunoglobulin G), IgM (Immunoglobulin M), IgA (Immunoglobulin A) 2) By Serum Albumin: Bovine Serum Albumin (BSA), Porcine Serum Albumin, Equine Serum Albumin 3) By Fibrinogen: Bovine Fibrinogen, Porcine Fibrinogen 4) By Other Types: Growth Factors, Cytokines, EnzymesWhat Is The Driver Of The Animal Derivatives Market?
The rising urbanization is expected to propel the growth of the animal derivatives market going forward. Urbanization refers to the increasing population concentration in urban areas, including the growth of cities and the expansion of urban land areas. Urbanization is increasing due to the growing availability of economic opportunities in cities. As urban areas offer more jobs, higher wages, and better access to essential services, people are moving from rural areas to take advantage of these benefits. The animal derivatives market supports the rising urbanization, as urban areas see a growing demand for animal-based products in food, pharmaceuticals, and other industries, driven by population growth and evolving consumer preferences. For instance, in March 2025, according to the Census Bureau, a US-based federal agency, between 2023 and 2024, the number of people living in U.S. metro (urban) areas rose by nearly 3.2 million (1.1% increase), reaching 293.9 million. Therefore, the rising urbanization is driving the growth of the animal derivatives industry.Key Players In The Global Animal Derivatives Market
Major companies operating in the animal derivatives market are ANZCO Foods Ltd., Rocky Mountain Biologicals Inc., Auckland BioSciences Ltd., LAMPIRE Biological Laboratories Inc., Proliant Biologics LLC, Sigma-Aldrich Co., Thermo Fisher Scientific Inc., Kedrion Biopharma Inc., LFB S.A, Octapharma AG, Takeda Pharmaceuticals Company, Sanofi S.A., Grifols S.A., Bayer AG, Commonwealth Serum Laboratories, Fusion Health Care Pvt. Ltd., Nippi Inc., Tessenderlo Group, Kewpie Corporation, Pure Ingredients, Ewald-Gelatine GmbH, Kerry Group, Darling International Inc., Gelken Gelatin Co. Ltd., Foodmate Co. Ltd., Weishardt Group, Trobas Gelatine BV, Nitta Gelatin Ltd., Gelita AG, Kraeber & Co. GmbHGlobal Animal Derivatives Market Trends and Insights
Major companies in the market are introducing innovative products such as PureeX to sustain their position in the market. PureeX refers to an advanced, nutrient-enhanced animal feed puree formulation designed to improve digestibility, palatability, and overall animal health. For instance, in April 2023, Protix, a Netherlands-based manufacturer of ingredients for food supplements, launched PureeX insect meat. The new product is freshly extracted from insects and is a very nutritious and appetizing ingredient to be used in pet foods. It also has a low carbon footprint, high antioxidant levels, and antimicrobial activity.What Are Latest Mergers And Acquisitions In The Animal Derivatives Market?
In September 2024, Anpario plc, a UK-based manufacturer of natural feed additives for livestock and aquaculture, acquired Bio-Vet Inc. for an undisclosed amount. The acquisition aligns with Anpario’s strategy to enhance its product offerings, increase its geographical footprint, and leverage Bio-Vet’s established market position in the U.S. livestock sector. Bio-Vet Inc. is a US-based producer of animal health and nutrition products.Regional Outlook
North America was the largest region in the animal derivatives market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Animal Derivatives Market?
The animal derivatives market consists of sales of gelatin, bone meal, flesh, milk, eggs and fish oil. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Animal Derivatives Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $14.06 billion |
| Revenue Forecast In 2035 | $18.27 billion |
| Growth Rate | CAGR of 6.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Animal Type, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | ANZCO Foods Ltd., Rocky Mountain Biologicals Inc., Auckland BioSciences Ltd., LAMPIRE Biological Laboratories Inc., Proliant Biologics LLC, Sigma-Aldrich Co., Thermo Fisher Scientific Inc., Kedrion Biopharma Inc., LFB S.A, Octapharma AG, Takeda Pharmaceuticals Company, Sanofi S.A., Grifols S.A., Bayer AG, Commonwealth Serum Laboratories, Fusion Health Care Pvt. Ltd., Nippi Inc., Tessenderlo Group, Kewpie Corporation, Pure Ingredients, Ewald-Gelatine GmbH, Kerry Group, Darling International Inc., Gelken Gelatin Co. Ltd., Foodmate Co. Ltd., Weishardt Group, Trobas Gelatine BV, Nitta Gelatin Ltd., Gelita AG, Kraeber & Co. GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
